ArticleAnnals of medicine and surgery (2012)2026
Multidisciplinary team management and the survival of head and neck cancer patients: a systematic review and meta-analysis.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Multidisciplinary teams (MDTs) in cancer care aim to improve patient outcomes by bringing together healthcare professionals from various specialties. This collaborative approach has been associated with improved decision-making and survival rates, particularly in the management of complex cases, such as head and neck cancer (HNC). Our study aimed to assess the impact of MDTs on overall survival (OS) in patients at different stages of HNC compared with those who received non-MDT care. Methods: A systematic search was performed following PRISMA guidelines in PubMed, Scopus, Embase, and Web of Science databases from inception to June 2024 for studies comparing MDT management of patients with HNC with conventional treatment. The review was registered in PROSPERO under the number CRD420251165637. Data analysis was conducted using Review Manager version 5.4. Results: A systematic review and meta-analysis were conducted, including nine studies with a total of 42 937 patients. The pooled analysis showed that MDT management was associated with a significant 13% improvement in survival rates for HNC patients (HR: 0.87, 95% CI: 0.78-0.97, Conclusion: MDTs can improve survival rates among patients with HNC. Their effect in stage IV disease remains inconclusive. Further research is needed to explore the economic impact of MDTs and their effectiveness in broader populations and advanced stages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.